---
title: "FDA Reconsiders Moderna’s mRNA Flu Vaccine"
summary: "The FDA has changed its mind and will now review Moderna’s new mRNA flu vaccine after rejecting the original application. The company wants approval for people aged 50‑64 and faster approval for those 65 and older. If approved by August, the shot could reach stores before next flu season. The reversal follows criticism that the earlier decision hurt vaccination rates and sparked debate about U.S. vaccine policy."
section: "US news"
category: "Medical Research News"
imageUrl: "https://media.guim.co.uk/34803c5b845a6a896d03be7a3c4f5050111aa346/392_0_3915_3132/500.jpg"
publishedAt: "2026-02-18T17:24:31Z"
guardianId: "us-news/2026/feb/18/fda-modern-mrna-flu-vaccine-reversal"
---

The FDA has changed its mind and will now review Moderna’s new mRNA flu vaccine after rejecting the original application. The company wants approval for people aged 50‑64 and faster approval for those 65 and older. If approved by August, the shot could reach stores before next flu season. The reversal follows criticism that the earlier decision hurt vaccination rates and sparked debate about U.S. vaccine policy.
